Significant differences in T cell receptor repertoires in lung adenocarcinomas with and without epidermal growth factor receptor mutations

Recent clinical trials of non‐small cell lung cancer with immune checkpoint inhibitors revealed that patients with epidermal growth factor receptor (EGFR) mutations had more unfavorable outcomes compared with those with wild‐type EGFR. However, the underlying mechanism for the link between EGFR muta...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyauchi, Eisaku, Matsuda, Tatsuo, Kiyotani, Kazuma, Low, Siew‐Kee, Hsu, Yu‐Wen, Tsukita, Yoko, Ichinose, Masakazu, Sakurada, Akira, Okada, Yoshinori, Saito, Ryoko, Nakamura, Yusuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398877/
https://www.ncbi.nlm.nih.gov/pubmed/30582659
http://dx.doi.org/10.1111/cas.13919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398877/
https://www.ncbi.nlm.nih.gov/pubmed/30582659
http://dx.doi.org/10.1111/cas.13919

Ejemplares similares